Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2024

24.01.2024 | Original Article

Applicability of Online Chat-Based Artificial Intelligence Models to Colorectal Cancer Screening

verfasst von: Joseph Atarere, Haider Naqvi, Christopher Haas, Comfort Adewunmi, Sumanth Bandaru, Rakesh Allamneni, Onyinye Ugonabo, Olachi Egbo, Mfoniso Umoren, Priyanka Kanth

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Over the past year, studies have shown potential in the applicability of ChatGPT in various medical specialties including cardiology and oncology. However, the application of ChatGPT and other online chat-based AI models to patient education and patient-physician communication on colorectal cancer screening has not been critically evaluated which is what we aimed to do in this study.

Methods

We posed 15 questions on important colorectal cancer screening concepts and 5 common questions asked by patients to the 3 most commonly used freely available artificial intelligence (AI) models. The responses provided by the AI models were graded for appropriateness and reliability using American College of Gastroenterology guidelines. The responses to each question provided by an AI model were graded as reliably appropriate (RA), reliably inappropriate (RI) and unreliable. Grader assessments were validated by the joint probability of agreement for two raters.

Results

ChatGPT and YouChat™ provided RA responses to the questions posed more often than BingChat. There were two questions that > 1 AI model provided unreliable responses to. ChatGPT did not provide references. BingChat misinterpreted some of the information it referenced. The age of CRC screening provided by YouChat™ was not consistently up-to-date. Inter-rater reliability for 2 raters was 89.2%.

Conclusion

Most responses provided by AI models on CRC screening were appropriate. Some limitations exist in their ability to correctly interpret medical literature and provide updated information in answering queries. Patients should consult their physicians for context on the recommendations made by these AI models.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Reif de Paula T, Haas EM, Keller DS. Colorectal cancer in the 45-to-50 age group in the United States: a National Cancer Database (NCDB) analysis. Surgical Endoscopy 2022;36:6629–6637.CrossRefPubMed Reif de Paula T, Haas EM, Keller DS. Colorectal cancer in the 45-to-50 age group in the United States: a National Cancer Database (NCDB) analysis. Surgical Endoscopy 2022;36:6629–6637.CrossRefPubMed
4.
Zurück zum Zitat Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Jama 2021;325:1965–1977.CrossRef Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Jama 2021;325:1965–1977.CrossRef
15.
Zurück zum Zitat Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. Journal of Ambient Intelligence and Humanized Computing, 2021;1–28. https://doi.org/10.1007/s12652-021-03612-z Kumar Y, Koul A, Singla R, Ijaz MF. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. Journal of Ambient Intelligence and Humanized Computing, 2021;1–28. https://​doi.​org/​10.​1007/​s12652-021-03612-z
23.
Zurück zum Zitat Kassab J, el Dahdah J, Chedid El Helou M, et al. Assessing the Accuracy of an Online Chat-Based Artificial Intelligence Model in Providing Recommendations on Hypertension Management in Accordance With the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines. Hypertension 2023;80(7). https://doi.org/10.1161/HYPERTENSIONAHA.123.21183 Kassab J, el Dahdah J, Chedid El Helou M, et al. Assessing the Accuracy of an Online Chat-Based Artificial Intelligence Model in Providing Recommendations on Hypertension Management in Accordance With the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines. Hypertension 2023;80(7). https://​doi.​org/​10.​1161/​HYPERTENSIONAHA.​123.​21183
Metadaten
Titel
Applicability of Online Chat-Based Artificial Intelligence Models to Colorectal Cancer Screening
verfasst von
Joseph Atarere
Haider Naqvi
Christopher Haas
Comfort Adewunmi
Sumanth Bandaru
Rakesh Allamneni
Onyinye Ugonabo
Olachi Egbo
Mfoniso Umoren
Priyanka Kanth
Publikationsdatum
24.01.2024
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2024
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08274-3

Weitere Artikel der Ausgabe 3/2024

Digestive Diseases and Sciences 3/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.